IPOPI’s 2024 Review of Activities and Achievements

In 2024, IPOPI continued to bring the global PID community together — connecting patients, experts, and advocates across 75 countries to improve lives and drive progress in care and diagnosis for people with primary immunodeficiencies (PIDs).

Highlights included the XVIII Global Patients’ Meeting in Marseille, new advocacy initiatives on plasma access and newborn screening, and the launch of our Research Grant Programme. IPOPI also embraced digital transformation and explored how artificial intelligence can shape the future of rare disease management.

As we look ahead, IPOPI remains committed to empowering patients, supporting our National Member Organisations, and driving equitable access to diagnosis and treatment worldwide.

Together, we continue to build a stronger, more connected global PID community.

We hope you will enjoy reading this annual report, which highlights the most significant IPOPI initiatives, campaigns, and events in the previous year.

Explore the annual review